PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance

por Tan, Catherine L., Kuchroo, Juhi R., Sage, Peter T., Liang, Dan, Francisco, Loise M., Buck, Jessica, Thaker, Youg Raj, Zhang, Qianxia, McArdel, Shannon L., Juneja, Vikram R., Lee, Sun Jung, Lovitch, Scott B., Lian, Christine, Murphy, George F., Blazar, Bruce R., Vignali, Dario A.A., Freeman, Gordon J., Sharpe, Arlene H.
Publicado 2020

PD-L1 – PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection

por Perry, Joseph A., Shallberg, Lindsey, Clark, Joseph T., Gullicksrud, Jodi, DeLong, Jonathan H., Douglas, Bonnie B., Hart, Andrew P., Lanzar, Zachary, O’Dea, Keenan, Konradt, Christoph, Park, Jeongho, Kuchroo, Juhi R., Grubaugh, Daniel, Zaretsky, Arielle Glatman, Brodsky, Igor E., Malefyt, Rene de Waal, Christian, David A., Sharpe, Arlene H., Hunter, Christopher A.
Publicado 2022

Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment

por Pauken, Kristen E., Shahid, Osmaan, Lagattuta, Kaitlyn A., Mahuron, Kelly M., Luber, Jacob M., Lowe, Margaret M., Huang, Linglin, Delaney, Conor, Long, Jaclyn M., Fung, Megan E., Newcomer, Kathleen, Tsai, Katy K., Chow, Melissa, Guinn, Samantha, Kuchroo, Juhi R., Burke, Kelly P., Schenkel, Jason M., Rosenblum, Michael D., Daud, Adil I., Sharpe, Arlene H., Singer, Meromit
Publicado 2021